Immunotherapy of patients with metastatic melanoma

Posted On 2017-07-21 15:21:33

Zhe Yu1, Lu Si2

1Department of Medical Oncology, The Second Affiliated Hospital, Dalian Medical University, Dalian 116044, China; 2The Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing 100142, China

Contributions: (I) Conception and design: L Si; (II) Administrative support: All authors; (III) Provision of study materials or patients: All authors; (IV) Collection and assembly of data: All authors; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.

Correspondence to: Prof. Lu Si, MD. The Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing 100142, China. Email: silu15_silu@126.com.

Read more>>